# Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome

> **NCT02330692** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 1000 (estimated)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02330692
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2023-07
- **Final completion:** 2023-09
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330692, "Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02330692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*